Sino Biopharmaceutical Limited: all 470 studies

Page 2 of 5. Open to participants first (164), then studies with results posted, then the rest; newest registration first within each.

• Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host DiseaseRecruitingNCT06682169Phase 3
• A Clinical Trial to Evaluate the Safety and Tolerability of TQB3911 Tablets in Patients With BCR::ABL Fusion Gene Positive LeukemiaNot yet recruitingNCT06672263Phase 1
• Drug-Drug Interaction (DDI) Study for TQB3616Not yet recruitingNCT06662773Phase 1
• Clinical Trial of TQB3002 in Patients With Advanced CancersRecruitingNCT06662760Phase 1
• Study of LM-299 in Subjects Advanced Malignant TumorsRecruitingNCT06650566Phase 1/2
• A Multicenter, Open Label Phase I Clinical Trial Evaluating the Safety and Pharmacokinetics of TQB2252 Injection in Subjects With Advanced Malignant TumorsNot yet recruitingNCT06649656Phase 1
• Clinical Trial of TQB2928 in Combination With a Third-Generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Non-Small Cell Lung CancersNot yet recruitingNCT06585059Phase 1
• Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH)RecruitingNCT06569524Phase 2
• A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell LymphomaRecruitingNCT06566586Phase 2
• A Clinical Trial to Evaluate the Efficacy and Safety of TQA3810 Tablets in Combination/Non Combination With Nucleoside (Acid) Analogues in Patients With Primary/Treated Chronic Hepatitis BRecruitingNCT06566248Phase 2
• A Phase 1 Clinical Trial of NTQ5082 in Healthy VolunteersNot yet recruitingNCT06560593Phase 1
• Effect of Food of NTQ5082 in Healthy SubjectsNot yet recruitingNCT06558656Phase 1
• A Clinical Trial of TQB3455 Tablets in Patients With Hematological MalignanciesRecruitingNCT06550713Phase 1
• A Study of Ramelteon in Chinese Patients With Chronic InsomniaNot yet recruitingNCT06512363Phase 3
• TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid TumorsNot yet recruitingNCT06500091Phase 2
• A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene AbnormalityRecruitingNCT06496490Phase 2
• Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial CancerNot yet recruitingNCT06475599Phase 3
• A Clinical Study of TQB2450 Combined With Anlotinib in Limited-Stage Small Cell Lung Cancer PatientsNot yet recruitingNCT06469879Phase 3
• The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast CancerRecruitingNCT06452706Phase 2
• A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis BNot yet recruitingNCT06452693Phase 1/2
• A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacokinetic of TQB3702 Tablets in Healthy Adult SubjectsRecruitingNCT06448273Phase 1
• The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic LymphomaNot yet recruitingNCT06434467Phase 3
• A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract CancerRecruitingNCT06431490Phase 1/2
• A Clinical Trial of TQB3117 Tablets in Patients With Advanced Malignant CancerNot yet recruitingNCT06415903Phase 1
• A Clinical Study of TQB3107 Tablets in Patients With Malignant TumorsRecruitingNCT06413953Phase 1
• Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed ShockRecruitingNCT06351150Phase 3
• A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host DiseaseRecruitingNCT06300320Phase 2
• D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy FailureRecruitingNCT06300177Phase 3
• A Study of TQB3454 Tablets in Patients With Blood TumorsRecruitingNCT06218771Phase 1/2
• A Phase Ib/II Clinical Study in Patients With Refractory Chronic CoughNot yet recruitingNCT06213363Phase 1/2
• A Clinical Trial of TQB3909 Tablets Combined With TQB3702 Tablets in Patients With Hematologic MalignancyNot yet recruitingNCT06211751Phase 1
• A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast CancerRecruitingNCT06202261Phase 1/2
• A Clinical Trial for the Treatment of Carbapenem Resistant Gram-negative Bacterial Infection With Colistimethate Sodium for InjectionRecruitingNCT06198764Phase 3
• Clinical Trial of TQB2922 for Injection in Patients With Advanced CancersRecruitingNCT06188624Phase 1
• A Study of LM-24C5 For Advanced Solid TumorsRecruitingNCT06187402Phase 1/2
• A Phase Ib/Ⅱ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast CancerRecruitingNCT06172322Phase 1
• A Study to Evaluate Drug-Drug Interaction of TQB3909 TabletsNot yet recruitingNCT06165822Phase 1
• Mass Balance Study of TQB3616Not yet recruitingNCT06149611Phase 1
• A Clinical Trial of TQB3454 Tablets in Healthy Adult SubjectsNot yet recruitingNCT06139367Phase 1
• A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)RecruitingNCT06122831Phase 1/2
• A Clinical Trial on the Treatment of Idiopathic Pulmonary FibrosisNot yet recruitingNCT06102083Phase 2
• A Clinical Trial of TQA3038 Injection in Healthy Adult SubjectsRecruitingNCT06085053Phase 1
• A Phase 1 Clinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological MalignanciesRecruitingNCT06049667Phase 1
• A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer.RecruitingNCT06010901Phase 1
• Clinical Trial Evaluating the Safety of the TQB2928 Injection Combination TherapyRecruitingNCT06008405Phase 1
• Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid CarcinomaRecruitingNCT05994365
• A Phase I/II Clinical Study in Patients with Advanced Solid Tumor.RecruitingNCT05970016Phase 1/2
• A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) .RecruitingNCT05959694Phase 1/2
• Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal SurgeryNot yet recruitingNCT05950152Phase 2
• A LM-302 Combination With Other Anti-Tumor Therapies Phase ll StudyRecruitingNCT05934331Phase 2
• Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy.RecruitingNCT05922345Phase 3
• A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung CancerRecruitingNCT05913089Phase 2
• TQB2223 Injection in Combination With Penpulimab in Patients With Advanced CancersRecruitingNCT05894421Phase 1
• Clinical Trial Evaluating the Safety of the TQB2103 for InjectionRecruitingNCT05867563Phase 1
• Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.RecruitingNCT05862337Phase 3
• Study of Anlotinib in Patients With Advanced Medullary Thyroid CarcinomaRecruitingNCT05830500Phase 4
• A Clinical Trial of TQB2618 Injection Combined With Penpulimab Injection and Chemotherapy Versus Penpulimab Injection Combined With Chemotherapy in First-line Treatment of Relapsed/Metastatic Head and Neck Squamous Cell CarcinomaRecruitingNCT05783921Phase 1/2
• TQB2450 Injection Combined With Chemotherapy Followed by Sequential Combination With Anlotinib Hydrochloride Capsule for First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer.Not yet recruitingNCT05718167Phase 3
• A Clinical Trial of TQB2934 for Injection in Multiple Myeloma SubjectsRecruitingNCT05646758Phase 1
• A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant TumorsRecruitingNCT05615974Phase 1/2
• A Study Evaluating Safety, Tolerability and Clinical Activity of FHND6091 in Patients With Multiple MyelomaRecruitingNCT05271682Phase 1
• A Clinical Study of Insulin Degludec Injection in Subjects With Type 2 DiabetesRecruitingNCT04955834Phase 3
• A Study to Evaluate the Tolerance and Pharmacokinetics of TQB2858 Injection in Subjects With Terminal Malignant TumorsRecruitingNCT04805060Phase 1
• FS222 First in Human Study in Patients With Advanced MalignanciesRecruitingNCT04740424Phase 1
• Bioequivalence Study of Mesylate Imatinib Capsule in Chronic Myeloid Leukemia BodyCompletedNCT01795716Phase 1Results posted
• QT Interval/Corrected QT Interval （QT/QTc） Clinical Study to Evaluate the Cardiac Safety of TQ05105 Tablets in Healthy ParticipantsActive, not recruitingNCT07708272Phase 1
• A Clinical Trial Comparing TQC3927 Inhaled Powder With Glycopyrronium Bromide and Formoterol Inhaled Aerosol (Biovoping® Lingchang®) for the Treatment of Chronic Obstructive Pulmonary DiseaseSuspendedNCT07633314Phase 2
• Study to Evaluate the Effect of Rabeprazole Sodium Enteric-coated Tablets on the Pharmacokinetics of TQ05105 TabletsActive, not recruitingNCT07608666Phase 1
• A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized Pustular PsoriasisTerminatedNCT07314060Phase 2
• A Clinical Trial of Mass Balance of [14C] TQ05105 in Healthy Chinese SubjectsCompletedNCT07293390Phase 1
• A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult SubjectsTerminatedNCT07267130Phase 1
• A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation PowderCompletedNCT07252908Phase 2
• Single and Multiple Ascending Doses and Food Effect Study of TRD205 in Healthy VolunteersCompletedNCT07123428Phase 1
• Clinical Trial of TQC2938 Injection in Patients With Seasonal Allergic RhinitisCompletedNCT07052097Phase 2
• A Clinical Trial to Evaluate the Efficacy and Safety of TQA3605 Tablets in Treatment-naive Chronic HBV-infected SubjectsWithdrawnNCT06990776Phase 2
• Clinical Trial to Evaluate the Tolerance of TQB2210 InjectionCompletedNCT06929195Phase 1
• Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung CancerTerminatedNCT06897579Phase 2
• Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast CancerTerminatedNCT06851442Phase 1/2
• A Clinical Study to Evaluate the Efficacy and Safety of TQC2938 in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseActive, not recruitingNCT06789289Phase 2
• Bioequivalence Test of Eltrombopag Olamine Tablets in Humans Under Fasting StateCompletedNCT06768632Not applicable
• Bioequivalence Study of Eltrombopag Olamine Tablets in Healthy Subjects in the Fed StateCompletedNCT06768619Not applicable
• A Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria PatientsActive, not recruitingNCT06764303Phase 2
• Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic RhinitisCompletedNCT06760182Phase 2
• A Clinical Study of TQC3721 Inhalation Powder in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT06748079Phase 1
• A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese SubjectsCompletedNCT06738979Phase 3
• A Clinical Trial of TQC3927 Powder for Inhalation in Chronic Obstructive Pulmonary DiseaseCompletedNCT06711991Phase 1
• A Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseActive, not recruitingNCT06707883Phase 2
• Evaluate TQ-A3334 Combined Nucleoside (Acid) Analogs in the First Treatment/Treatment of Chronic HBV InfectionActive, not recruitingNCT06706310Phase 2
• Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast CancerActive, not recruitingNCT06702618Phase 2
• To Evaluate the Pharmacokinetics and Safety of TQD3606 for Injection in Subjects With Renal InsufficiencyCompletedNCT06672276Phase 1
• Clinical Study of TQA3605 Tablets Combined With Nucleoside (Acid) Analogs (NAs) Drugs Compared With NAs Drugs in the Treatment of Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT06644417Phase 2
• To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Renal Impairment SubjectsCompletedNCT06598956Phase 1
• A Clinical Trial of TQB2102 for Injection in the Treatment of HER2 Low-Expressing Recurrent/Metastatic Breast CancerActive, not recruitingNCT06561607Phase 3
• To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic DermatitisActive, not recruitingNCT06552520Phase 3
• Safety, Tolerability, and Pharmacokinetics of a Single or Multiple Ascending Doses of CPX101CompletedNCT06545162Phase 1
• Treatment of Moderate to Severe Plaque PsoriasisCompletedNCT06542614Phase 2
• Evaluate the Safety and Efficacy of CPX101 in Overweight and Obese Subjects Without Diabetes MellitusCompletedNCT06532578Phase 2
• A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT06527144Phase 2
• To Evaluate the Pharmacokinetics and Safety of TQD3524 for Injection in Renal Impairment SubjectsCompletedNCT06522945Phase 1
• A Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 TabletsTerminatedNCT06507891Phase 1/2

← Sino Biopharmaceutical Limited overview and focus areas